NCT04942080Recruiting
Interest of CALR Allele Burden in Diagnosis and Follow-up of Patients With CALR Mutated Myeloproliferative Syndromes (CALRSUIVI)
Source: ClinicalTrials.gov · Last updated 6 Mar 2026
Brief summary (registry, in English)
Prospective study to evaluate the relevance of CALR allele burden monitoring as a molecular marker of disease progression.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 260 (estimated)
- First submitted
- 9 Jun 2021
- Start date
- 28 Oct 2021
- Primary completion date
- 28 Apr 2027
- Lead sponsor
- University Hospital, Angers
- Diseases
- Myeloproliferative neoplasms
- NCT number
- NCT04942080
What you commit to
- Study type: Interventional
- Planned participants: 260
- From 28 Oct 2021 to the primary completion date, 28 Apr 2027
- 10 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- patient with another active hematological disease or cancer at the time of diagnosis,
Other
- person subject to legal protection scheme or incapable of giving consent.
Who the study is looking for
- adults (age ≥18 years),
- affiliated to the national social security system,
- with CALR mutated myeloproliferative neoplasm diagnosed between 2006 - 2020,
- for which at least one sample is available at the time of diagnosis or before cytoreductive treatment,
- who signed the consent to participate in the study,
- included, or consenting to be included, in the national clinical-biological database of France Intergroupe Syndrome Myéloprolifératifs (FIM).
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (10)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| CHU Angers Coordinator of this site? Confirm its status | Angers | France | Recruiting |
| CHU Bordeaux Coordinator of this site? Confirm its status | Bordeaux | France | Recruiting |
| Chu Brest Coordinator of this site? Confirm its status | Brest | France | Recruiting |
| CH Cholet Coordinator of this site? Confirm its status | Cholet | France | Recruiting |
| CH Le Mans Coordinator of this site? Confirm its status | Le Mans | France | Recruiting |
| CH Morlaix Coordinator of this site? Confirm its status | Morlaix | France | Recruiting |
| AP-HP Henri Mondor Coordinator of this site? Confirm its status | Paris | France | Recruiting |
| CHU Poitiers Coordinator of this site? Confirm its status | Poitiers | France | Recruiting |
| CH Quimper Coordinator of this site? Confirm its status | Quimper | France | Recruiting |
| CHU Tours Coordinator of this site? Confirm its status | Tours | France | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.